PLXS Rule 144 Notice: 3,000 Shares Planned Sale on NASDAQ
Rhea-AI Filing Summary
Plexus Corp (PLXS) Form 144 notice: A proposed sale of 3,000 shares of common stock is reported through Morgan Stanley Smith Barney LLC, with an aggregate market value of $417,000 and approximately 26,986,726 shares outstanding. The approximate date of sale is 08/28/2025 on NASDAQ. The securities were acquired from the issuer as restricted stock and performance shares on 01/27/2023 (1,480 shares), 01/25/2024 (155 shares), and 02/13/2024 (1,365 shares). No securities of the issuer were reported sold by the person in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.
Positive
- Compliance with Rule 144 disclosure by filing a notice for the proposed sale
- Brokered sale through a major brokerage (Morgan Stanley Smith Barney LLC) indicating standard execution
Negative
- Insider selling is planned (3,000 shares, aggregate value $417,000), which some investors monitor
- No information in this filing about the identity of the selling person (name/CIK not provided in the text)
Insights
TL;DR: Routine insider sale notice for a modest block of shares, unlikely to be material relative to total outstanding stock.
The filing reports a proposed sale of 3,000 common shares valued at $417,000 against 26,986,726 shares outstanding, which represents a very small fraction of the outstanding share base. The shares were originally granted as restricted stock and performance shares across three dates in 2023 and 2024, and no sales in the prior three months are reported. Because this is a Rule 144 notice of a proposed sale through a broker, it documents an intended transaction rather than a completed, market-moving disposition. The filing includes the seller's attestation that no undisclosed material adverse information exists.
TL;DR: Standard compliance disclosure reflecting planned sale of vested/vestable equity; procedural rather than governance-changing.
The details show the securities originated from issuer grants (restricted stock and performance shares) with payment noted as not applicable, consistent with compensation-origin equity. The use of Morgan Stanley Smith Barney LLC as the executing broker and the Rule 144 notice format indicate adherence to resale reporting requirements. There are no indications in this filing of unusual governance actions, related-party transactions, or clustered insider selling that would raise immediate governance concerns.
FAQ
What does Plexus Corp's (PLXS) Form 144 report?
Does the filing show recent sales by the same person?
Who is the broker handling the proposed sale?
What attestation is included in the Form 144?